0001683168-21-000554.txt : 20210216
0001683168-21-000554.hdr.sgml : 20210216
20210212174226
ACCESSION NUMBER: 0001683168-21-000554
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20210216
DATE AS OF CHANGE: 20210212
EFFECTIVENESS DATE: 20210216
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Phio Pharmaceuticals Corp.
CENTRAL INDEX KEY: 0001533040
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-389435
FILM NUMBER: 21630175
BUSINESS ADDRESS:
STREET 1: 257 SIMARANO DRIVE
STREET 2: SUITE 101
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752
BUSINESS PHONE: (508) 767-3861
MAIL ADDRESS:
STREET 1: 257 SIMARANO DRIVE
STREET 2: SUITE 101
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752
FORMER COMPANY:
FORMER CONFORMED NAME: RXi Pharmaceuticals Corp
DATE OF NAME CHANGE: 20111019
D
1
primary_doc.xml
X0708
D
LIVE
0001533040
Phio Pharmaceuticals Corp.
257 SIMARANO DRIVE
SUITE 101
MARLBOROUGH
MA
MASSACHUSETTS
01752
508-767-3861
DELAWARE
RXi Pharmaceuticals Corporation
RXi Pharmaceuticals Corp
Corporation
true
Gerrit
Dispersyn
c/o Phio Pharmaceuticals Corp
257 Simarano Drive, Suite 101
Marlborough
MA
MASSACHUSETTS
01752
Executive Officer
Director
Caitlin
Kontulis
c/o Phio Pharmaceuticals Corp
257 Simarano Drive, Suite 101
Marlborough
MA
MASSACHUSETTS
01752
Executive Officer
Geert
Cauwenbergh
c/o Phio Pharmaceuticals Corp
257 Simarano Drive, Suite 101
Marlborough
MA
MASSACHUSETTS
01752
Director
Robert
J
Bitterman
c/o Phio Pharmaceuticals Corp
257 Simarano Drive, Suite 101
Marlborough
MA
MASSACHUSETTS
01752
Director
H
Paul
Dorman
c/o Phio Pharmaceuticals Corp
257 Simarano Drive, Suite 101
Marlborough
MA
MASSACHUSETTS
01752
Director
Jonathan
Freeman
c/o Phio Pharmaceuticals Corp
257 Simarano Drive, Suite 101
Marlborough
MA
MASSACHUSETTS
01752
Director
Curtis
A
Lockshin
c/o Phio Pharmaceuticals Corp
257 Simarano Drive, Suite 101
Marlborough
MA
MASSACHUSETTS
01752
Director
Robert
Ferrara
c/o Phio Pharmaceuticals Corp
257 Simarano Drive, Suite 101
Marlborough
MA
MASSACHUSETTS
01752
Director
Pharmaceuticals
Decline to Disclose
- 06b
false
2021-01-25
false
true
true
true
false
0
H.C. Wainwright & Co., LLC
375
None
None
430 PARK AVENUE
NEW YORK
NY
NEW YORK
10002
IL
ILLINOIS
NV
NEVADA
NJ
NEW JERSEY
NY
NEW YORK
TX
TEXAS
false
24264137
14001909
10262228
The offering amount includes amounts receivable by the Issuer upon the exercise of warrants to purchase the Issuer's common stock (assuming no cashless exercise).
false
14
1190174
0
H.C. Wainwright & Co., LLC, the placement agent for the private placement, received $1,190,174.16 for fees and warrants to purchase up to 342,070 shares of common stock at an exercise price of $3.8375 per share.
0
false
Phio Pharmaceuticals Corp.
/s/ Gerrit Dispersyn
Gerrit Dispersyn
President & CEO
2021-02-12